Evidence map›Paper›PMID 9765394›Full record

ArticleJournal of virology1998

The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.

Z Gao, A Krithivas, J E Finan, O J Semmes, S Zhou, Y Wang, S D Hayward

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Z GaoMolecular Virology Laboratories, Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland 21205-2185, USA.
A Krithivas
J E Finan
O J Semmes
S Zhou
Y Wang
S D Hayward
Laboratory of Molecular Genetics · PL

Funding

TRAINING IN ANTICANCER DRUG DEVELOPMENTT32CA009243 · NCI · JOHNS HOPKINS UNIVERSITY · PI STIVERS, JAMES T. · 1985 to 2012
$6.2M
EBV GENOME EXPRESSION:LOCALIZATION OF SPECIFIC FUNCTIONSR01CA030356 · NCI · JOHNS HOPKINS UNIVERSITY · PI HAYWARD, S DIANE · 1986 to 2009
$3.3M
NCI NIH HHS 5 T32 CA09243NCI NIH HHS R01 CA030356NCI NIH HHS R01 CA30356NCI NIH HHS T32 CA009243
6 · The paper itself

Abstract

The Epstein-Barr virus transactivator Zta triggers lytic gene expression and is essential for replication of the lytic origin, oriLyt. Previous analysis indicated that the Zta activation domain contributed a replication-specific function. We now show that the Zta activation domain interacts with components of the EBV helicase-primase complex. The three helicase-primase proteins BBLF4 (helicase), BSLF1 (primase), and BBLF2/3 (primase-associated factor) were expressed fused to the Myc epitope. When expression plasmids for BBLF4 or BBLF2/3 plus BSLF1 (primase subcomplex) were separately transfected, the proteins localized to the cytoplasm. Interaction between Zta and the components of the helicase-primase complex was tested by examining the ability of Zta to alter the intracellular localization of these proteins. Cotransfection of Zta with Myc-BBLF4 resulted in nuclear translocation of Myc-BBLF4; similarly, cotransfection of Zta with the primase subcomplex led to nuclear translocation of the Myc-BSLF1 and Myc-BBLF2/3 proteins. This relocalization provides evidence for an interaction between Zta and the helicase and Zta and the primase subcomplex. An affinity assay using glutathione S-transferase-Zta fusion proteins demonstrated that Myc-BBLF4 and Myc-BBLF2/3 plus BSLF1 bound to the Zta activation domain (amino acids 1 to 133). In the nuclear relocalization assay, the amino-terminal 25 amino acids of Zta were required for efficient interaction with the primase subcomplex but not for interaction with BBLF4. Evidence for interaction between oriLyt bound Zta and the helicase-primase complex was obtained in a superactivation assay using an oriLyt-chloramphenicol acetyltransferase (CAT) reporter. Zta activated expression from a CAT reporter containing the complete oriLyt region and regulated by the oriLyt BHLF1 promoter. Cotransfection of the helicase-primase proteins, one of which was fused to a heterologous activation domain, led to Zta-dependent superactivation of CAT expression. This assay also provided evidence for an interaction between the single-stranded DNA binding protein, BALF2, and the Zta-tethered helicase-primase complex. The helicase-primase interaction is consistent with a role for Zta in stabilizing the formation of an origin-bound replication complex.

Indexed as

AnimalsAntigens, ViralBase SequenceChloramphenicol O-AcetyltransferaseChlorocebus aethiopsDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA HelicasesDNA PrimaseDNA PrimersGenes, ReporterHerpesvirus 4, HumanMacromolecular SubstancesPolymerase Chain ReactionRecombinant Fusion ProteinsReplication OriginAntigens, ViralBALF2 protein, Human herpesvirus 4BALF5 protein, Epstein-barr virusBZLF1 protein, Herpesvirus 4, HumanChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA HelicasesDNA PrimaseDNA PrimersEpstein-Barr virus early antigen diffuse componentMacromolecular SubstancesRecombinant Fusion ProteinsTrans-ActivatorsViral Proteins

Identifiers

PMID9765394
PMCPMC110266
OpenAlexW1856337372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.